» Articles » PMID: 28698665

Antigens Rv0310c and Rv1255c Are Promising Novel Biomarkers for the Diagnosis of Mycobacterium Tuberculosis Infection

Overview
Date 2017 Jul 13
PMID 28698665
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to identify novel immunogenic epitopes from Mycobacterium tuberculosis (MTB) that could be used in tuberculosis (TB) diagnostics. To determine the diagnostic potential of mycobacterial antigens in serodiagnosis of TB, 256 patients were enrolled in a study and divided into two groups: 126 smear-positive pulmonary TB patients (SPPT) and 130 smear-negative pulmonary TB patients (SNPT); 152 bacillus Calmette-Guerin (BCG)-vaccinated healthy people were used as a control. Murine results showed that antigens Rv0310c-E from RD 8 and Rv1255c-E from RD 10 were strongly immunogenic to Th1 cells and induced a great humoral response. Receiver operating characteristic analysis indicated that Rv0310c-E (area under the curve (AUC): 0.800) and Rv1255c-E (AUC: 0.808) performed better than ESAT-6 (AUC: 0.665) and CFP-10 (AUC: 0.623) proteins but were comparable with Rv3425 (AUC: 0.788) protein in a human serum IgG analysis. Rv0310c-E demonstrated the highest diagnostic ability for the SPPT group (Youden index: 0.5602, sensitivity: 69.84%, specificity: 86.18%), while Rv1255c-E demonstrated the highest diagnostic ability for the SNPT group (Youden index: 0.5674, sensitivity: 73.84%, specificity: 82.89%). In addition, combination analysis found that antigen Rv0310c-E, coupled with the Rv3425 protein (Youden index: 0.6098, sensitivity: 87.30%, specificity: 73.68%) had the strongest performance for TB diagnostics of the SPPT group, and the single antigen Rv1255c-E was strongest for the SNPT group. These results suggest that antigens Rv0310c-E and Rv1255c-E are potential antigens for TB serodiagnostic tests, which may facilitate detection of MTB in smear-negative and smear-positive patients.

Citing Articles

Antibodies as key mediators of protection against .

Wang Q, Nag D, Baldwin S, Coler R, McNamara R Front Immunol. 2024; 15:1430955.

PMID: 39286260 PMC: 11402706. DOI: 10.3389/fimmu.2024.1430955.


Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis.

Li X, Zhao W, Han H, Yang Z, Bi F, He Y Saudi Med J. 2024; 45(7):658-666.

PMID: 38955446 PMC: 11237276. DOI: 10.15537/smj.2024.45.7.20240310.


Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection.

Wang J, Jiang F, Cheng P, Ye Z, Li L, Yang L Mol Biomed. 2024; 5(1):15.

PMID: 38679629 PMC: 11056354. DOI: 10.1186/s43556-024-00177-z.


Antibodies as clinical tools for tuberculosis.

McIntyre S, Warner J, Rush C, Vanderven H Front Immunol. 2024; 14:1278947.

PMID: 38162666 PMC: 10755875. DOI: 10.3389/fimmu.2023.1278947.


Advancing personalized medicine for tuberculosis through the application of immune profiling.

Thu V, Dat L, Jayanti R, Trinh H, Hung T, Cho Y Front Cell Infect Microbiol. 2023; 13:1108155.

PMID: 36844400 PMC: 9950414. DOI: 10.3389/fcimb.2023.1108155.


References
1.
Zhang H, Wang J, Lei J, Zhang M, Yang Y, Chen Y . PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients. Clin Microbiol Infect. 2007; 13(2):139-145. DOI: 10.1111/j.1469-0691.2006.01561.x. View

2.
Amenuvegbe G, Francis A, Fred B . Low tuberculosis case detection: a community and health facility based study of contributory factors in the Nkwanta South district of Ghana. BMC Res Notes. 2016; 9:330. PMC: 4928284. DOI: 10.1186/s13104-016-2136-x. View

3.
Hur Y, Kim A, Kang Y, Kim A, Kim D, Kim Y . Evaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts. J Clin Microbiol. 2015; 53(3):904-9. PMC: 4390664. DOI: 10.1128/JCM.03050-14. View

4.
Getahun H, Harrington M, OBrien R, Nunn P . Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007; 369(9578):2042-2049. DOI: 10.1016/S0140-6736(07)60284-0. View

5.
Zagursky R, Russell D . Bioinformatics: use in bacterial vaccine discovery. Biotechniques. 2001; 31(3):636, 638, 640, passim. DOI: 10.2144/01313dd02. View